Diabetes and Endocrine Unit, ASL TO5, Via De Maria, 1, 10023, Chieri, TO, Italy.
Epidemiology Unit, ASL TO3, Regione Piemonte, Grugliasco, TO, Italy.
Acta Diabetol. 2018 Jul;55(7):733-740. doi: 10.1007/s00592-018-1142-y. Epub 2018 Apr 20.
To study the incidence of and the factors associated with renal dialysis and transplantation in type 1 (T1DM) and type 2 diabetes (T2DM).
Data on individuals who had received dialysis treatment or renal transplant between 1 January 2004 and 31 December 2013 were extracted from the regional administrative database (Piedmont, Italy), and the crude (cumulative) incidence of dialysis was calculated. Overall cumulative survival was estimated using the Kaplan-Meier method and compared using the log-rank test. Poisson regression was used to estimate adjusted rate ratios for potential predictors of renal transplant or death.
A total of 7401 persons started dialysis treatment during the decade, with a 10-year cumulative crude incidence of 16.8/100,000. Incidence was stable and consistently eightfold higher in persons with T2DM (tenfold higher in T1DM) compared to those without diabetes. The risk of dialysis in T1DM was about double that of T2DM. The mortality rate was significantly higher in diabetics than in non-diabetes (241.4/1000 vs. 153.99/1000 person-years). During the decade 2004-2013, 893 patients underwent a kidney transplant. Transplantation rates were significantly lower for diabetics than non-diabetics (16.5/1000 vs. 42.9/1000 person-years).
In the past decade, the incidence of dialysis has stabilized in both the general population and in diabetics in whom it remains far higher by comparison. Also mortality rates are higher, with a worse prognosis for T1DM. Diabetes poses a barrier to allotransplantation, and efforts should be made to overcome this limitation.
研究 1 型(T1DM)和 2 型糖尿病(T2DM)患者中接受透析和移植的发生率及相关因素。
从区域行政数据库(意大利皮埃蒙特)中提取了 2004 年 1 月 1 日至 2013 年 12 月 31 日期间接受透析治疗或肾移植的个体数据,并计算了透析的粗(累积)发生率。使用 Kaplan-Meier 法估计总体累积生存率,并使用对数秩检验进行比较。使用泊松回归估计潜在预测因素的校正率比,以预测肾移植或死亡的风险。
在这十年中,共有 7401 人开始透析治疗,10 年累积粗发生率为 16.8/100000。在 T2DM 患者中,发病率稳定且始终是糖尿病患者的 8 倍(T1DM 患者的发病率是糖尿病患者的 10 倍)。与 T2DM 相比,T1DM 患者的透析风险约为其两倍。与非糖尿病患者相比,糖尿病患者的死亡率明显更高(241.4/1000 与 153.99/1000 人年)。在 2004 年至 2013 年的十年间,893 名患者接受了肾移植。与非糖尿病患者相比,糖尿病患者的移植率明显较低(16.5/1000 与 42.9/1000 人年)。
在过去的十年中,普通人群和糖尿病患者的透析发病率均已稳定,而糖尿病患者的发病率仍高得多。此外,死亡率更高,T1DM 的预后更差。糖尿病对同种异体移植构成障碍,应努力克服这一限制。